VOOPOO
7.1.2022 13:02:14 CET | Business Wire | Press release
At the start of the new year 2022, VOOPOO , always in pursuit of unique industrial designs, has made another big move. On January 5, it launched Vinci Pod Royal Edition with a new relief design. Its shining and lightweight overall shape emphasizes a retro feel while also showing a strong aristocratic atmosphere.
Original relief craftsmanship for Pod
A large number of relief artworks have been unearthed from the ancient Sumerian Ruins, one of the birthplaces of human civilization. In contemporary times, there are also plenty of art products using relief craftsmanship. According to Vivian, Head of VOOPOO Product Development Team, “It is precisely the ancient relief artworks and the fashionable and retro contemporary elements that inspired us to develop the Vinci Pod Royal Edition series. Our original purpose is to explore the artistic and cultural value of the Pod product itself, so that users can also show their artistic taste in the process of using the product.”
However, it is no easy to engrave relief patterns on delicate Pod products. Any slight fault in the process will result in failure to achieve art-grade quality. The six products of the VOOPOO Vinci Pod Royal Edition series are all designed by experienced artists and are also integrated with design elements from retro jazz and cool graffiti styles. Product development took 8 months, and 12 manufacture processes and 68 techniques were involved, with 80% of the work completed by hand. The products were a result of the collaboration of more than 20 people including industrial designers, structural designers, and R&D members.
In addition to the unique relief itself, the tactile experience brought by the relief is even more impressive. Since the relief pattern of each product is different, customers can choose according to their own visual and tactile preferences. When the Pod of "tactile beauty" is held in your hand, you can experience an artistic masterpiece with its concave-convex surface, allowing you to enjoy a noble experience at your fingertip.
Focused on the user's product experience
In addition to the appearance, the product’s material and user experience also fit the users’ habits. The VOOPOO product development team has chosen the 6061 aviation-grade aluminum alloy, which boasts excellent strength, plasticity, fracture toughness, fatigue resistance, stress corrosion cracking resistance and exfoliation corrosion resistance, and has been widely used in aerospace, high-speed rail and automotive industries. It is worth noting that after 268 precise airflow experiments, the transmitter and airway design of VINCI Pod Royal Edition has been well optimized, bringing unparalleled comfort to the mouth-sucking experience.
VINCI Pod Royal Edition comes with the visual VINCI POD cartridge, which allows users to see the remaining e-liquid in real time, so that they can refill in time and refrain from anxiety. At the same time, VINCI Pod Royal Edition is equipped with 0.8Ω and 1.2Ω atomizers for users to enjoy different levels of taste and nicotine experience according to their preferences. VINCI Pod Royal Edition has also perfectly integrated the breathing light, so that it lights up when the user is inhaling, and goes off when stopping, providing users the strong dynamic sense.
WARNING: This product may be used with e-liquid products containing nicotine. Nicotine is an addictive chemical.
Voopoo website: https://www.voopoo.com/
IG: https://www.instagram.com/voopoo_global/
https://www.instagram.com/voopootechofficial/
Facebook: https://www.facebook.com/Voopootech/
Tiktok: https://www.tiktok.com/@voopoo_indonesia?lang=en
Please view the original press release at businesswire.com: https://www.businesswire.com/news/home/20220105006068/zh-CN/
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220105006058/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom